. .
.
. Mayo Clinic Health Solutions
.
. .
.
Search:
Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

GLTSCR1 Gene Analysis for Prostate Cancer

Reference #:

2004-162

Inventors/Contributors

Stephen N. Thibodeau, Ph.D., Daniel J. Schaid, Ph.D., Steven J. Jacobsen, M.D., Ph.D., Jennifer C. Guenther, Liang Wang, M.D., Ph.D., Scott J. Hebbring, Susan L. Slager, Ph.D., Shannon K. McDonnell, Julie M. Cunningham, Ph.D., James R. Cerhan, M.D., Ph.D.

Description

Identification of GLTSCR1 gene mutations to predict susceptibility to prostate cancer and to preduct prostate cancer aggressiveness.

Patent Status

None

Contact

Susan L. Stoddard, Ph.D., Licensing Manager
sstoddard@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 284-1222
Fax: (507) 284-5410